Navigation Links
GlaxoSmithKline Share Their Insight on Understanding DDI With a View to Better Prediction and Control
Date:6/28/2012

LONDON, June 28, 2012 /PRNewswire/ --

Pharma IQ has released a new interview with Dr. James Clarke, Senior Scientist, GlaxoSmithKline, on the biggest challenges for clinically relevant drug transporters that GSK faces.

In this exclusive podcast Dr. Clarke shares his knowledge on how drug transporters exert a vital influence on drug absorption, disposition, metabolism and elimination and why they are an essential part of predicting drug disposition. He provides ideas on how the current technology landscape changed following the publication of the ITC white paper and the progress we can expect to see in clinically relevant drug transporters.

This interview was created as a part of the pre-conference research for the 3rd Annual Clinically Relevant Drug Transporters, taking place from the 22nd- 24th  October, 2012 in London.

The interview helped to shape the summit agenda which features among others - Eva Gil Berglund, PhD, Medical Products Agency, Sweden and Keith Hoffmaster, Senior Investigator from Novartis (ITC member) who provide an insight into new developments in the FDA / EMA transporter interaction Draft Guidance Papers.

Other important topics which will be discussed at the event include:

  • Model-based Prediction of Transporter-mediated Disposition and DDIs (Manthena Varma, Principle Scientist, Pfizer)
  • Drug Targeting: how can we use Uptake Transporters to achieve CNS or Tumour Penetration  (Maarten Huisman, Janssen Pharmaceutical Companies)
  • De-risking conjugated metabolites for causing transporter DDI with toxicological implications (Timothy Shultz - Utermoehl, Shire Pharmaceuticals)
  • Impact of "transporter-metabolism" and "transporter-transporter" interplay in Raloxifene Disposition (Jae Chang, Research Scientist, Genentech)

Press are invited to attend this important industry forum. If you would like to a complimentary press pass please email Joanna Checinska (joanna.checinska@iqpc.co.uk)

To access Dr. James Clarke's full interview or find out more about the Clinically Relevant Drug Transporters Summit please visit http://www.drugrtransporters/news, email enquire@iqpc.co.uk or call +44(0)207-930-1300.

Media contact: Joanna Checinska, +44(0)20-7368-9807, joanna.checinska@iqpc.co.uk  - Please contact for more information or images.


'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Employees Embark on Long-Term Volunteer Assignments throughout the World
2. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
3. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
4. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
5. Heska Announces Quarterly Dividend of $0.10 Per Share
6. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
7. OncoSec Medical Issues Letter to Shareholders
8. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
9. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
10. Omnyx Share Their Insight on Agile Software Development for Medical Devices
11. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):